Antidiabetic medication de-escalation following bariatric surgery

J Diabetes. 2018 Sep;10(9):768-770. doi: 10.1111/1753-0407.12779. Epub 2018 May 28.

Authors

Scott M Vouri^{1

2}, Jiajing Chen³, Jayme Sparkman⁴, Arghavan Salles⁴, Scott T Micek^{1

2}

Affiliations

¹ St. Louis College of Pharmacy, Department of Pharmacy Practice, St. Louis, Missouri, USA.
² St. Louis College of Pharmacy, Center for Health Outcomes Research and Education, St. Louis, Missouri, USA.
³ Center for Outcomes Research, Saint Louis University, St. Louis, Missouri, USA.
⁴ Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

PMID: 29736976
DOI: 10.1111/1753-0407.12779

No abstract available

Keywords: bariatric surgery; diabetes mellitus; medication de-escalation; pharmacoepidemiology.

Publication types

Letter

MeSH terms

Bariatric Surgery / methods*
Diabetes Mellitus, Type 2 / prevention & control*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Male
Middle Aged
Obesity / surgery*

Substances

Hypoglycemic Agents